Takeda Pharmaceutical
TAK
A$23.55
Share price
1.45%
Change (1 day)
17.62%
Change (1 year)
Categories
Revenue for Takeda Pharmaceutical (TAK)
Revenue in 2024 (TTM): A$45.49 Billion
According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM 
) is A$45.86 Billion. an increase over the revenue in the year 2023 that were of A$43.07 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Takeda Pharmaceutical from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | A$48.18 B | 11.86% |
| 2023 | A$43.07 B | -0.95% |
| 2022 | A$43.49 B | 1.86% |
| 2021 | A$42.69 B | 8.8% |
| 2020 | A$39.24 B | -7.49% |
| 2019 | A$42.42 B | 85.09% |
| 2018 | A$22.92 B | 12.51% |
| 2017 | A$20.37 B | -8.27% |
| 2016 | A$22.20 B | 6.67% |
| 2015 | A$20.81 B | 5.82% |
| 2014 | A$19.67 B | 5.24% |
| 2013 | A$18.69 B | 0.91% |
| 2012 | A$18.52 B | 2.63% |
| 2011 | A$18.05 B | 11.68% |
| 2010 | A$16.16 B | -6.45% |
| 2009 | A$17.28 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | A$136.69 B | 198.04% | 🇺🇸 USA |
 Sanofi SNY | A$72.58 B | 58.25% | 🇫🇷 France |
 Pfizer PFE | A$95.58 B | 108.40% | 🇺🇸 USA |
 Novartis NVS | A$81.44 B | 77.57% | 🇨🇭 Switzerland |
 Seagen
SGEN | A$3.51 B | -92.33% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | A$5.66 B | -87.65% | 🇮🇳 India |
 Amgen AMGN | A$52.21 B | 13.86% | 🇺🇸 USA |
 GlaxoSmithKline GSK | A$62.13 B | 35.48% | 🇬🇧 UK |
 Merck MRK | A$97.81 B | 113.27% | 🇺🇸 USA |